Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis
Accumulating evidence suggests that hyperuricemia is a pathological factor in the development and progression of chronic kidney disease. However, the potential benefit afforded by the control of uric acid (UA) is controversial. Individual studies show discrepant results, and most existing meta-analysis, especially those including the larger number of studies, lack a placebo or control group as they aim to compare efficacy between drugs. On these grounds, we performed a me-ta-analysis restricted to studies including the action of any anti-gout therapies referenced to a control or placebo arm. This approach allows for a clea...
Source: Frontiers in Pharmacology - March 26, 2024 Category: Drugs & Pharmacology Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: J Rheumatol - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: Journal of Rheumatology - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: J Rheumatol - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: Journal of Rheumatology - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: J Rheumatol - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: Journal of Rheumatology - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: J Rheumatol - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: Journal of Rheumatology - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: J Rheumatol - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: Journal of Rheumatology - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: J Rheumatol - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: Journal of Rheumatology - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: J Rheumatol - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
What is allopurinol "failure" and what should we do about it?
J Rheumatol. 2024 Mar 15:jrheum.2024-0144. doi: 10.3899/jrheum.2024-0144. Online ahead of print.ABSTRACTAllopurinol is the most widely used urate-lowering medication world-wide. However, allopurinol "failure" is frequently observed in clinical practice. In this review, we provide a framework for assessing allopurinol "failure", which includes failure of allopurinol to control serum urate concentrations, failure of allopurinol to control clinical symptoms, and failure of allopurinol due to an adverse drug reaction. Understanding the causes of allopurinol "failure" underpins the approach required to turn "failure" into "succ...
Source: Journal of Rheumatology - March 15, 2024 Category: Rheumatology Authors: Lisa K Stamp Nicola Dalbeth Source Type: research
